INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

9480	Companies
185550	Keywords
117941	Articles
99385	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 04/15/2025 at 22:00, 7 months 19 days ago

Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
Inventiva dépose son Document d’Enregistrement Universel 2024 et son Rapport Annuel 2024 (Form 20-F) auprès de l’AMF et de la SEC. Les documents sont disponibles sur les sites internet respectifs

AMF SEC Inventiva Rapport Annuel 2024 Document D'Enregistrement Universel 2024
BRIEF

published on 03/26/2025 at 21:05, 8 months 10 days ago

Inventiva dévoile ses résultats financiers 2024 et ses projets stratégiques

Réorganisation Stratégique Résultats Financiers 2024 Recherche & Développement Lanifibranor Financement Structuré
BRIEF

published on 03/26/2025 at 21:05, 8 months 10 days ago

Inventiva unveils its 2024 financial results and strategic projects

Strategic Reorganization 2024 Financial Results Research & Development Lanifibranor Structured Financing
PRESS RELEASE

published on 03/26/2025 at 21:00, 8 months 10 days ago

Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité
Inventiva publie ses résultats financiers annuels 2024 et fait le point sur son activité avec chiffre d'affaires de 9,2 millions d'euros, trésorerie à 96,6 millions d'euros et levée de 116 millions d'euros

Chiffre D'affaires Résultats Financiers Financement Trésorerie Inventiva
PRESS RELEASE

published on 03/26/2025 at 21:00, 8 months 10 days ago

Inventiva reports its 2024 full year results and provides a business update
Inventiva reports its 2024 full year financial results with revenues of €9.2 million, cash equivalents of €96.6 million and a structured financing of up to €348 million. Significant progress in the NATiV3 Phase 3 trial of lanifibranor for MASH. Pipeline prioritization plan presented

Revenues Financial Results Inventiva Cash Equivalents NATiV3 Phase 3 Trial
BRIEF

published on 03/19/2025 at 21:05, 8 months 17 days ago

Inventiva Announces 2024 Full-Year Financial Results Schedule

Financial Results Webcast Inventiva Lanifibranor MASH Treatment
BRIEF

published on 03/19/2025 at 21:05, 8 months 17 days ago

Inventiva annonce le calendrier des résultats financiers annuels 2024

Résultats Financiers Webcast Inventiva Lanifibranor Traitement MASH
PRESS RELEASE

published on 03/19/2025 at 21:00, 8 months 17 days ago

Inventiva announces the schedule of publication and presentation of its 2024 Full-Year Financial Results
Inventiva schedules 2024 Full-Year Financial Results presentation on March 27, 2025. Webcast available. Company focused on small molecule therapies for MASH

Presentation 2024 Financial Results Inventiva MASH Small Molecule Therapies
PRESS RELEASE

published on 03/19/2025 at 21:00, 8 months 17 days ago

Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024
Inventiva annonce la date de publication et de présentation de ses résultats financiers 2024. La présentation aura lieu le 27 mars 2025 avec une conférence téléphonique le 30 mars 2025

Presentation Conférence Téléphonique Thérapies Orales Résultats Financiers 2024 Inventiva
BRIEF

published on 02/26/2025 at 22:05, 9 months 6 days ago

Inventiva's Lanifibranor Shows Promise in Portal Hypertension Study

Preclinical Study Inventiva Liver Disease Lanifibranor Portal Hypertension

Accesswire

Published on 12/05/2025 at 21:20, 10 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 30 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 5 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 1 hour 15 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 1 hour 40 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 2 hours 32 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 3 hours 3 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 3 hours 14 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 3 hours 38 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 3 hours 44 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 4 hours 12 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 12 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 19 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 19 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 7 hours 31 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE